| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $4.8B | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| R&D Expense | — | — |
| SG&A Expense | — | — |
| Operating Income | — | — |
| Net Income | $2.4B | $0.5B |
| EPS (Basic) | — | — |
| EPS (Diluted) | — | — |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $17.0B | $4.4B |
| Current Assets | — | — |
| Cash & Equivalents | $1.6B | $0.0B |
| Total Liabilities | $6.7B | $1.1B |
| Current Liabilities | — | — |
| Stockholders' Equity | — | $3.2B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $2.1B | $0.6B |
| Investing Cash Flow | $-0.3B | $-0.0B |
| Capital Expenditures | — | — |
| Financing Cash Flow | $-0.6B | $-0.6B |